AAPLLoadingMSFTLoadingNVDALoadingGOOGLLoadingAMZNLoadingMETALoadingTSLALoadingAMDLoadingNFLXLoadingCOINLoadingPYPLLoadingSPYLoadingQQQLoadingIWMLoadingJPMLoadingVLoadingDISLoadingKOLoadingJNJLoadingNKELoadingXOMLoadingASMLLoading
FreeSYK3 min read

Procedure volumes are the device industry's demand signal

It last traded at 294.69, -0.60% on the session. Device companies report product launches, acquisitions and guidance. The number underneath all of it is how many procedures hospitals are performing.

SYK
Delayed

Why volume leads everything

An implant is sold when a surgery happens. Capital equipment is bought when a hospital expects enough surgeries to justify it. Both follow procedure volume, which follows demographics, hospital staffing and how long patients have been waiting.

That makes procedure volume the closest thing this industry has to a demand indicator, and it moves more slowly and more predictably than almost anything else in healthcare.

What I track

  • Procedure volume commentary from hospitals and insurers, which arrives before the device makers report
  • Hospital capital budgets, since equipment orders follow confidence in future volume
  • Pricing in the major implant categories, where large purchasing groups negotiate hard
  • The mix between elective procedures, which can be delayed, and those that cannot

An ageing population is not a forecast. It is arithmetic that has already been done.

Where I stand

Long. Elective procedure demand has a demographic floor under it, and a broad portfolio across implants and hospital equipment captures volume wherever it shows up. Pricing pressure is real and persistent, and the view depends on volume staying the larger force.

What would change my mind

Procedure growth slowing while hospital capital budgets tighten. Volume and equipment moving down together would mean the demand floor is lower than the demographics suggest.

The author holds no position in the instruments discussed. Opinion. Not advice. Not a financial promotion approved under FSMA s.21. Quote data is delayed. Past performance is not a reliable indicator of future results.

Comments

0 comments
Sign in to comment.

No comments yet

Be the first to weigh in.